Polyrizon Hits Key Milestone

Polyrizon has completed a significant step in the development process of its allergy blocker, having finished contracting for trial sites. This milestone marks a major advancement in the company's efforts to bring its allergy blocker to market.

## What's Next The completion of trial site contracting is a crucial step in the development process, as it allows Polyrizon to move forward with the next stages of testing and evaluation.

## Why it Matters The development of an effective allergy blocker has the potential to make a significant impact on the lives of individuals who suffer from allergies. By completing the contracting for trial sites, Polyrizon is one step closer to bringing this potentially life-changing treatment to those who need it.

The company's progress in the development of its allergy blocker is a positive sign for the future of allergy treatment. As Polyrizon continues to move forward with its plans, it will be important to monitor its progress and see how its allergy blocker performs in trials.